Learning hematology in 2025 with Nico Gagelmann: Part 3

Learning hematology in 2025 with Nico Gagelmann: Part 3

Nico Gagelman is a physician and scientist who co-founded and co-chairs the European Society for Blood and Marrow Transplantation (EBMT) Trainee Committee, and he also serves as the chair of the EBMT subcommittee focused on CAR-T cell therapies for plasma cell disorders.

His work is particularly impactful in the realm of CAR-T treatments for multiple myeloma, where he has contributed to advancing research and clinical approaches.

Nico Gagelmann

Recently Nico Gagelmann began a new series on X titled ‘Let’s Learn Hematology in 2025.’ Here’s the third part of his educational journey:

“Evaluation of hemolysis”

hematology

“Hemophilia characteristics”

Learning hematology in 2025 with Nico Gagelmann: Part 3

“How to manage febrile neutropenia”

Learning hematology in 2025 with Nico Gagelmann: Part 3

“Hyperleukocytosis”

Learning hematology in 2025 with Nico Gagelmann: Part 3

“Targeted therapies in CLL”

Learning hematology in 2025 with Nico Gagelmann: Part 3

“Bone marrow in aplastic anemia”

Learning hematology in 2025 with Nico Gagelmann: Part 3

“Hemoglobin degradation”

Learning hematology in 2025 with Nico Gagelmann: Part 3

“Synthesis and function of von Willebrand factor”

Learning hematology in 2025 with Nico Gagelmann: Part 3

“Thrombocytopenia in liver cirrhosis”

Learning hematology in 2025 with Nico Gagelmann: Part 3

“Malignancy-associated haemophagocytic lymphohistiocytosis”

Learning hematology in 2025 with Nico Gagelmann: Part 3

Nico Gagelmann: Let’s learn hematology in 2025: Part 1

Learning hematology in 2025 with Nico Gagelmann: Part 2